Kevin K Ohrr

Title: **Kevin K. Ohrr: Innovator in Pharmaceutical Synthesis**

Introduction

Kevin K. Ohrr, based in Saint Charles, Missouri, is an accomplished inventor with a strong focus on pharmaceutical innovations. With a total of two patents to his name, Ohrr has made significant contributions to the field of anticoagulant synthesis, particularly through his work on Fondaparinux sodium.

Latest Patents

His latest patents revolve around an efficient and scalable process for the manufacture of Fondaparinux sodium, an important Factor Xa anticoagulant. This invention details the synthesis process of Fondaparinux and its related compounds. Moreover, it encompasses methods for efficiently synthesizing various intermediates that are essential for the production of Fondaparinux and its derivatives.

Career Highlights

Kevin K. Ohrr is currently affiliated with Reliable Biopharmaceutical Corporation, where he applies his expertise in pharmaceutical chemistry to develop new drug synthesis methods. His work not only enhances the efficiency of drug production but also contributes to the overall field of biopharmaceuticals.

Collaborations

Throughout his career, Ohrr has collaborated with talented coworkers such as Payal Parth Patel and Chun Ma. These collaborations highlight his commitment to teamwork and innovation in advancing scientific research and development.

Conclusion

Kevin K. Ohrr stands out as a notable inventor in the pharmaceutical sector. His breakthroughs in the synthesis of Fondaparinux sodium exemplify his dedication to enhancing drug manufacturing processes. With his ongoing contributions to Reliable Biopharmaceutical Corporation, Ohrr continues to impact the field positively, fostering advancements in medical science and patient care.